Protein kinase C and endothelial dysfunction in select vascular diseases
Authors:
Open Access
- 25 August 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 12, 1618343
Abstract
Protein kinases have crucial roles in intracellular signal transduction pathways that affect a wide range of biochemical processes, including apoptosis, metabolism, proliferation, and protein synthesis. Vascular endothelial cells are important regulators of vasomotor tone, tissue/organ perfusion, and inflammation. Since its discovery in the late 1970s, a growing body of literature implicates protein kinase C (PKC) in pathways involving angiogenesis, endothelial permeability, microvascular tone, and endothelial activation. Hence the objective of this review, to characterize the role of PKC in vascular endothelial cells. After discussing the basic principles of PKC structure and function, the focus shifts to abnormal PKC activity driving endothelial dysfunction in three major pathologies whose hallmark is significant vascular disease: diabetes mellitus, hypoxia/ischemia-reperfusion injury, and hypertension. Themes addressed include endothelial cell cycle derangement, endothelial oxidative stress, endothelial activation/inflammation, and impaired endothelial barrier integrity. Achieving a comprehensive understanding of endothelial cell-PKC pathophysiology may lead to development of new therapeutic targets for mitigating morbidity and mortality in these disease states.Keywords
This publication has 162 references indexed in Scilit:
- Prevalence of Diabetic Retinopathy in the US in 2021JAMA Ophthalmology, 2023
- Protein kinase C-β distinctly regulates blood-brain barrier-forming capacity of Brain Microvascular endothelial cells and outgrowth endothelial cellsMetabolic Brain Disease, 2022
- Global trends in diabetes complications: a review of current evidenceDiabetologia, 2018
- Activation of general control nonderepressible 2 kinase protects human glomerular endothelial cells from harmful high-glucose-induced molecular pathwaysInternational Urology and Nephrology, 2016
- A PKC-β inhibitor protects against cardiac microvascular ischemia reperfusion injury in diabetic ratsApoptosis, 2010
- Selective PKC Beta Inhibition with Ruboxistaurin and Endothelial Function in Type-2 Diabetes MellitusCardiovascular Drugs and Therapy, 2008
- Mechanisms related to the cardioprotective effects of protein kinase C epsilon (PKC ɛ) peptide activator or inhibitor in rat ischemia/reperfusion injuryNaunyn-Schmiedeberg's Archives of Pharmacology, 2008
- Reactive oxygen species mediate a cellular ‘memory’ of high glucose stress signallingDiabetologia, 2007
- Protein kinase C and downstream signaling pathways in a three-dimensional model of phorbol ester-induced angiogenesisAngiogenesis, 2006
- The Role of Endothelin, Protein Kinase C and Free Radicals in the Mechanism of the Post-ischemic Endothelial Dysfunction in Guinea-pig HeartsJournal of Molecular and Cellular Cardiology, 2000